Literature DB >> 8042550

The effect of Nicorandil on chronic cerebral vasospasm.

T Matsui1, T Nagafuji, K Tsutsumi, H Uchida, T Miyauchi, T Asano.   

Abstract

The present study is aimed at examining the therapeutic effect of Nicorandil on chronic vasospasm using beagle dogs subjected to a "two-haemorrhage" insult, as well as its dilatory effect on the PDA [phorbol-12,13 diacetate]-induced contraction of the canine basilar artery. 1. A total of 12 animals of either sex, weighing 7 to 12 kg, were assigned into saline control and Nicorandil-treated groups. Immediately after the second induction of subarachnoid haemorrhage (SAH), animals started to receive the agent via the venous route at the constant rate of 10 micrograms/kg/minute for six hours (day 3). On days 4, 5, and 6, the drug was given twice at the same rate for three hours. After the final angiograms, animals were sacrificed by exsanguination. 2. Using ring specimen of the canine basilar artery at a resting tension of 3 g, isometric tension was monitored to examine the effect of Nicorandil on PDA induced contraction. Nicorandil significantly ameliorated chronic vasospasm and inhibited PDA-induced contraction in a dose-dependent fashion. The present data indicate that Nicorandil provides a useful way of treating chronic vasospasm after SAH.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8042550     DOI: 10.1007/bf01476428

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  30 in total

Review 1.  Protein kinase C in the regulation of smooth muscle contraction.

Authors:  H Rasmussen; Y Takuwa; S Park
Journal:  FASEB J       Date:  1987-09       Impact factor: 5.191

Review 2.  Mechanisms of action of transmitters and other substances on smooth muscle.

Authors:  T B Bolton
Journal:  Physiol Rev       Date:  1979-07       Impact factor: 37.312

3.  Cerebral arterial spasm. 1. In vitro contractile activity of vasoactive agents on canine basilar and middle cerebral arteries.

Authors:  G S Allen; L M Henderson; S N Chou; L A French
Journal:  J Neurosurg       Date:  1974-04       Impact factor: 5.115

4.  Activation of the protein kinase C-mediated contractile system in canine basilar artery undergoing chronic vasospasm.

Authors:  T Matsui; M Sugawa; H Johshita; Y Takuwa; T Asano
Journal:  Stroke       Date:  1991-09       Impact factor: 7.914

5.  Pharmacological profile of a new coronary vasodilator drug, 2-nicotinamidoethyl nitrate (SG-75).

Authors:  N Taira; K Satoh; T Yanagisawa; Y Imai; M Hiwatari
Journal:  Clin Exp Pharmacol Physiol       Date:  1979 May-Jun       Impact factor: 2.557

6.  Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension.

Authors:  I A Awad; L P Carter; R F Spetzler; M Medina; F C Williams
Journal:  Stroke       Date:  1987 Mar-Apr       Impact factor: 7.914

7.  Effect of the nonglucocorticoid 21-aminosteroid U74006F experimental cerebral vasospasm.

Authors:  D G Vollmer; N F Kassell; K Hongo; H Ogawa; T Tsukahara
Journal:  Surg Neurol       Date:  1989-03

8.  Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a "two-hemorrhage" canine model.

Authors:  V G Varsos; T M Liszczak; D H Han; J P Kistler; J Vielma; P M Black; R C Heros; N T Zervas
Journal:  J Neurosurg       Date:  1983-01       Impact factor: 5.115

9.  Reduced production of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage.

Authors:  P Kim; V B Schini; T M Sundt; P M Vanhoutte
Journal:  Circ Res       Date:  1992-02       Impact factor: 17.367

10.  A dosage study of the effect of the 21-aminosteroid U74006F on chronic cerebral vasospasm in a primate model.

Authors:  K Kanamaru; B K Weir; J M Findlay; M Grace; R L Macdonald
Journal:  Neurosurgery       Date:  1990-07       Impact factor: 4.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.